What if you could fix disease by rewriting DNA? From CRISPR to next-gen gene editing, Stephanie Sirota and Beam Therapeutics CEO John Evans break down base editing, prime editing, and the path to one-time cures.

PODCAST TEAM

Producer & Director: Devon Leaver

Editor: Dominique Guerra

Production Coordinator: Ying Yu Lin

Production support: Annabelle Chan

Executive Editorial Advisor: Stephanie Sirota

Research Consultant: Piratip Pratumsuwan

Theme music by: Yehezkel Raz

Additional music: APM Music

Featuring: John Evans, CEO and Board Member of Beam Therapeutics, moderated by Stephanie Sirota, Partner and Chief Business Officer at RTW Investments.

FOLLOW US

Love our podcast? Follow us on LinkedIn at